Screener
Absci Corporation ABSI Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Absci Corporation in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Absci Corporation’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:24 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001672688-26-000088
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $8,825 | 2,756 |
| Accrued compensation | 2,217 | 6,615 |
| Accrued preclinical and clinical development expenses | 2,549 | 6,350 |
| Accrued other | 3,719 | 3,627 |
| Total accounts payable and accrued expenses | $17,310 | $19,348 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Absci Corporation's accounts payable?
- Absci Corporation (ABSI) reported accounts payable of $8.83M in Q1 2026.
- How has Absci Corporation's accounts payable changed year-over-year?
- Absci Corporation's accounts payable increased by 78.4% year-over-year, from $4.95M to $8.83M.
- What is the long-term trend for Absci Corporation's accounts payable?
- Over 4 years (2021 to 2025), Absci Corporation's accounts payable has grown at a -4.9% compound annual growth rate (CAGR), from $25.02M to $20.5M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Absci Corporation's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude